Matches in Wikidata for { <http://www.wikidata.org/entity/Q93227744> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- Q93227744 description "artículu científicu espublizáu n'abril de 2020" @default.
- Q93227744 description "im April 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q93227744 description "scientific article published on 22 April 2020" @default.
- Q93227744 description "wetenschappelijk artikel" @default.
- Q93227744 description "наукова стаття, опублікована 22 квітня 2020" @default.
- Q93227744 name "Efficacy and safety of proposed bevacizumab biosimilar BE1040V in patients with metastatic colorectal cancer: A phase III, randomized, double-blind, noninferiority clinical trial" @default.
- Q93227744 name "Efficacy and safety of proposed bevacizumab biosimilar BE1040V in patients with metastatic colorectal cancer: A phase III, randomized, double-blind, noninferiority clinical trial" @default.
- Q93227744 type Item @default.
- Q93227744 label "Efficacy and safety of proposed bevacizumab biosimilar BE1040V in patients with metastatic colorectal cancer: A phase III, randomized, double-blind, noninferiority clinical trial" @default.
- Q93227744 label "Efficacy and safety of proposed bevacizumab biosimilar BE1040V in patients with metastatic colorectal cancer: A phase III, randomized, double-blind, noninferiority clinical trial" @default.
- Q93227744 prefLabel "Efficacy and safety of proposed bevacizumab biosimilar BE1040V in patients with metastatic colorectal cancer: A phase III, randomized, double-blind, noninferiority clinical trial" @default.
- Q93227744 prefLabel "Efficacy and safety of proposed bevacizumab biosimilar BE1040V in patients with metastatic colorectal cancer: A phase III, randomized, double-blind, noninferiority clinical trial" @default.
- Q93227744 P1433 Q93227744-A3FFF740-5E71-4292-AC3E-99E1A2D737A8 @default.
- Q93227744 P1476 Q93227744-636B3353-0C30-4D70-91F4-8D6BA2D05EFC @default.
- Q93227744 P2093 Q93227744-0B3A2FDB-2EBB-42C4-B027-B440D755C38B @default.
- Q93227744 P2093 Q93227744-100D9937-0811-4824-9920-E511DBD7932E @default.
- Q93227744 P2093 Q93227744-12FF3700-2623-488C-A987-FAE6777E4EEE @default.
- Q93227744 P2093 Q93227744-19EB4FC3-8412-4DB2-9281-9CF2DFF56227 @default.
- Q93227744 P2093 Q93227744-3068AF0F-FE25-45FA-8171-77CF1682A739 @default.
- Q93227744 P2093 Q93227744-38A529DA-E4F3-4001-AA9B-8A1AE5CD062B @default.
- Q93227744 P2093 Q93227744-56374B04-03B5-47A9-A2E2-38483E3016C6 @default.
- Q93227744 P2093 Q93227744-6A245C37-29FA-4395-ADD6-5367B17FDD11 @default.
- Q93227744 P2093 Q93227744-6EC23330-0963-4B95-86A5-9A38449FFF07 @default.
- Q93227744 P2093 Q93227744-74ABD153-EB6A-44C1-999B-93D9F7FCDCBD @default.
- Q93227744 P2093 Q93227744-7B40DE82-C3F6-43C5-B259-319C2C38B95F @default.
- Q93227744 P2093 Q93227744-A7B0AD7E-E2EA-4EAB-8DAF-A299882B65BF @default.
- Q93227744 P2093 Q93227744-B02F348C-8A5E-4088-88AF-12FA4639A25A @default.
- Q93227744 P2093 Q93227744-B5CFF614-2C8F-4041-8925-6C7A27108307 @default.
- Q93227744 P2093 Q93227744-B6660A53-121D-486D-A69B-036C7F9EDC15 @default.
- Q93227744 P2093 Q93227744-C822C8B5-7424-45C6-ABBC-0F68AE6814E4 @default.
- Q93227744 P2093 Q93227744-CF911B47-E9E5-4E36-8E3B-F61899E2D875 @default.
- Q93227744 P2093 Q93227744-D141C20C-1B68-49B1-9359-043E5A333CC9 @default.
- Q93227744 P2093 Q93227744-EF64013D-EE3C-491E-907B-387D6A14C801 @default.
- Q93227744 P2093 Q93227744-F5B287D7-BB7D-47C6-8DE6-E79662D0FAF2 @default.
- Q93227744 P2093 Q93227744-FD21842B-E28F-4A68-B3C8-D58248B2EF02 @default.
- Q93227744 P31 Q93227744-7C0639E0-7292-462C-8990-2B8ECF79E7AC @default.
- Q93227744 P356 Q93227744-F7496ECF-CD19-4BB1-8CF6-2E87C62BEFC1 @default.
- Q93227744 P577 Q93227744-7EB4FC9D-ECA3-43DC-B0FB-970D39BF55C3 @default.
- Q93227744 P698 Q93227744-3DD9698A-B6F0-4D6F-967E-B599BDBEFBA2 @default.
- Q93227744 P921 Q93227744-263D7548-70E7-4A9C-9419-376B6432F706 @default.
- Q93227744 P921 Q93227744-675EF4E5-F481-41AC-91BE-8C5038495DB1 @default.
- Q93227744 P921 Q93227744-9D21FF1C-2B86-48F6-92EF-7174B5E9BFBC @default.
- Q93227744 P921 Q93227744-B187D6BC-252D-4C77-B62F-C018875EF986 @default.
- Q93227744 P356 J.CLINTHERA.2020.03.009 @default.
- Q93227744 P698 32334845 @default.
- Q93227744 P1433 Q15716601 @default.
- Q93227744 P1476 "Efficacy and safety of proposed bevacizumab biosimilar BE1040V in patients with metastatic colorectal cancer: A phase III, randomized, double-blind, noninferiority clinical trial" @default.
- Q93227744 P2093 "Abolghasem Allahyari" @default.
- Q93227744 P2093 "Adnan Khosravi" @default.
- Q93227744 P2093 "Afsaneh Alikhasi" @default.
- Q93227744 P2093 "Ali Hajiqolami" @default.
- Q93227744 P2093 "Alireza Rezvani" @default.
- Q93227744 P2093 "Alireza Sadeghi" @default.
- Q93227744 P2093 "Amirabbas Nekuee" @default.
- Q93227744 P2093 "Babak Shazad" @default.
- Q93227744 P2093 "Hamid Rezvani" @default.
- Q93227744 P2093 "Mehrdad Payandeh" @default.
- Q93227744 P2093 "Moein Karbalaeian" @default.
- Q93227744 P2093 "Mohammadreza Vahidfar" @default.
- Q93227744 P2093 "Mohsen Esfandbod" @default.
- Q93227744 P2093 "Mohsen Rajaeinejad" @default.
- Q93227744 P2093 "Mojtaba Ghadyani" @default.
- Q93227744 P2093 "Nassim Anjidani" @default.
- Q93227744 P2093 "Safa Najjar Najafi" @default.
- Q93227744 P2093 "Seyed Mohammadreza Mortazavizadeh" @default.
- Q93227744 P2093 "Shahab Meskinimood" @default.
- Q93227744 P2093 "Sina Salari" @default.
- Q93227744 P2093 "Siroos Qarib" @default.
- Q93227744 P31 Q13442814 @default.
- Q93227744 P356 "10.1016/J.CLINTHERA.2020.03.009" @default.
- Q93227744 P577 "2020-04-22T00:00:00Z" @default.
- Q93227744 P698 "32334845" @default.
- Q93227744 P921 Q108566365 @default.
- Q93227744 P921 Q188874 @default.
- Q93227744 P921 Q413299 @default.
- Q93227744 P921 Q42824827 @default.